These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 34178927)
1. Does Fecal Microbiota Transplant Have a Role in Treating Recurrent Vedala K; Sobash P; Shah P; Kamoga GR Front Public Health; 2021; 9():670941. PubMed ID: 34178927 [No Abstract] [Full Text] [Related]
3. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement. Chauhan A; Apostolov R; van Langenberg D; Garg M Intern Med J; 2021 Jan; 51(1):106-110. PubMed ID: 33572016 [TBL] [Abstract][Full Text] [Related]
4. An overview of Miguel A Br J Nurs; 2023 Jun; 32(12):546-549. PubMed ID: 37344135 [No Abstract] [Full Text] [Related]
5. Clinical outcomes after faecal microbiota transplant by retention enema in both immunocompetent and immunocompromised patients with recurrent Clostridioides difficile infections at an academic medical centre. Navalkele BD; Polistico J; Sandhu A; Awali R; Krishna A; Chandramohan S; Tillotson G; Chopra T J Hosp Infect; 2020 Dec; 106(4):643-648. PubMed ID: 32991940 [TBL] [Abstract][Full Text] [Related]
6. A Systematic Review of Fecal Microbiota Transplantation Versus Vancomycin for Treatment of Recurrent Clostridioides difficile Infection. Leung J; Pham S Gastroenterol Nurs; 2021 Mar-Apr 01; 44(2):106-115. PubMed ID: 33795620 [TBL] [Abstract][Full Text] [Related]
8. Clinical practice guidelines for Clostridioides (Clostridium) difficile infection and fecal microbiota transplant protocol - recommendations of the Polish Society od Epidemiology and Infectious Diseases. Piekarska A; Panasiuk A; Stępień PM Przegl Epidemiol; 2020; 74(1):69-87. PubMed ID: 32500988 [TBL] [Abstract][Full Text] [Related]
9. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection. Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405 [TBL] [Abstract][Full Text] [Related]
10. AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases. Peery AF; Kelly CR; Kao D; Vaughn BP; Lebwohl B; Singh S; Imdad A; Altayar O; Gastroenterology; 2024 Mar; 166(3):409-434. PubMed ID: 38395525 [TBL] [Abstract][Full Text] [Related]
11. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence. Luo Y; Tixier EN; Grinspan AM Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714 [TBL] [Abstract][Full Text] [Related]
12. Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial. Orenstein R; Dubberke ER; Khanna S; Lee CH; Yoho D; Johnson S; Hecht G; DuPont HL; Gerding DN; Blount KF; Mische S; Harvey A BMC Infect Dis; 2022 Mar; 22(1):245. PubMed ID: 35279084 [TBL] [Abstract][Full Text] [Related]
13. Management of Severe and Severe/Complicated Clostridoides difficile Infection Using Sequential Fecal Microbiota Transplant by Retention Enema. Rupawala AH; Gachette D; Bakhit M; Jimoh L; Kelly CR Clin Infect Dis; 2021 Aug; 73(4):716-719. PubMed ID: 33476379 [TBL] [Abstract][Full Text] [Related]
14. Fecal Microbiota Transplant for Clostridium difficile Infection in a Pregnant Patient. Saeedi BJ; Morison DG; Kraft CS; Dhere T Obstet Gynecol; 2017 Mar; 129(3):507-509. PubMed ID: 28178052 [TBL] [Abstract][Full Text] [Related]
15. Cortés P; Bi Y; Stancampiano F; Valery JR; Cooper JH; Harris DM Rom J Intern Med; 2021 Sep; 59(3):262-269. PubMed ID: 33713592 [No Abstract] [Full Text] [Related]
16. Freeze-dried fecal samples are biologically active after long-lasting storage and suited to fecal microbiota transplantation in a preclinical murine model of Reygner J; Charrueau C; Delannoy J; Mayeur C; Robert V; Cuinat C; Meylheuc T; Mauras A; Augustin J; Nicolis I; Modoux M; Joly F; Waligora-Dupriet AJ; Thomas M; Kapel N Gut Microbes; 2020 Sep; 11(5):1405-1422. PubMed ID: 32501140 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection. Shaffer SR; Witt J; Targownik LE; Kao D; Lee C; Smieliauskas F; Rubin DT; Singh H; Bernstein CN J Infect; 2020 Nov; 81(5):758-765. PubMed ID: 32980389 [TBL] [Abstract][Full Text] [Related]
18. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis. Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622 [TBL] [Abstract][Full Text] [Related]
20. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'. Tan X; Johnson S Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]